TrialPediatric blood & cancer2014

Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.

Amulya A Nageswara Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.